Is Comera Life Sciences Holdings, Inc. (CMRA) a Buy, Sell, or Hold?
OTC : CMRA
Comera Life Sciences Holdings, Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 730
- Average Volume
- 948
- Market Capitalization
- $3.07K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.61
Company Overview
OTC
Michael G. Campbell
Biotechnology
Healthcare
CMRA
12
US
USD
Liquidity Metrics
-0.12
0.61
0.61
0.09
0.00
Sales & Valuation
$633.1K
0.00
0.00
0.00
-0.94
Profitability
-$1.76
-$18M
-2843.79%
-2843.79%
47452.88%
-483.06%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-28.11
2/9
-$301.92K
$3.07M
$7.29M
-$8.98M
Key Metrics (TTM)
$331.52K
0.52
-0.02
0.61
47452.88%
1768.56%
-1722435.65%
-318815.13%
-2510 days
Company Executives
| Name | Title |
|---|---|
| Michael G. Campbell | Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer |
| Janice Marie McCourt | Chief Business Officer |
| David Soane | Co-Founder & Member of Scientific Advisory Board |
Poll Results
No votes yet today — be the first to share your view!
About Comera Life Sciences Holdings, Inc. (OTC:CMRA) Stock
Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platform, engineered to transform intravenous (IV) biologic drugs into more convenient subcutaneous (SQ) injectable forms. Currently, the company is progressing two main product candidates: CLS-001, an early-stage "biobetter" designed to treat inflammatory bowel conditions like Crohn's and Ulcerative Colitis, and CLS-002, another preclinical biobetter aimed at diverse oncology indications. Established in 2014, Comera Life Sciences is headquartered in Woburn, Massachusetts. ...
Frequently Asked Questions
-
What is the current Comera Life Sciences Holdings, Inc. (CMRA) stock price?
-
Comera Life Sciences Holdings, Inc.(OTC:CMRA) stock price is $0.0001 in the last trading session. During the trading session, CMRA stock reached the peak price of $0.0002 while $0.0001 was the lowest point it dropped to. The percentage change in CMRA stock occurred in the recent session was 0.0% while the dollar amount for the price change in CMRA stock was $0.
-
CMRA's industry and sector of operation?
-
The OTC listed CMRA is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of CMRA?
-
Michael G. Campbell | Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer
Janice Marie McCourt | Chief Business Officer
David Soane | Co-Founder & Member of Scientific Advisory Board
|
| -
How many employees does CMRA have?
-
Number of CMRA employees currently stands at 12. CMRA operates from 12 Gill Street, Woburn, MA 01801, US.
-
Link for CMRA official website?
-
Official Website of CMRA is: https://comeralifesciences.com
-
How do I contact CMRA?
-
CMRA could be contacted at phone #617 871 2101 and can also be accessed through its website. CMRA operates from 12 Gill Street, Woburn, MA 01801, US.
-
How many shares of CMRA are traded daily?
-
The average number of CMRA shares traded daily for last 3 months was 948.
-
What is the market cap of CMRA currently?
-
The market value of CMRA currently stands at $3.07K with its latest stock price at $0.0001